However, the TB-IRIS group demonstrated significantly higher increases in CD4 + T-cell counts compared to the non-TB-IRIS group at the end of 24 weeks (P = 0.004) and at 48 weeks (P = 0.015). This evidence concerns the gene CD4 and tuberculosis.